Gavreto
Pralsetinib
- Strength
- 100 mg/1
- Form
- Capsule
- Class
- Kinase Inhibitor
Genentech, Inc.
Not stocked by us — reference only
Pralsetinib
Listed by Rigel Pharmaceuticals, Inc.
| Dosage form | Capsule |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 71332-006 |
| FDA application | NDA213721 |
| RxNorm concept | 2394941 |
| Package sizes listed | 3 |
| Marketed since | June 2024 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Pralsetinib
Genentech, Inc.
Not stocked by us — reference only
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.